By analyzing the expression of BMP effectors in pDMG tumors and patient-derived DIPG models, we propose that the activation of this pathway in ACVR1 WT H3.3K27M tumors could be at least partially mediated by two complementary tumor-autonomous and microenvironment-dependent mechanisms. This evidence concerns the gene ACVR1 and neoplasm.